X-135985673-C-G

Variant summary

Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS1

This summary comes from the ClinGen Evidence Repository: The allele frequency of the p.Ile5Met variant in SLC9A6 is 0.013% in Ashkenazi Jewish sub population in gnomAD, which is high enough to be classified as likely benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BS1). Computational analysis prediction tools suggest that the p.Ile5Met variant does not have a deleterious impact; however this information does not predict clinical significance on its own (BP4). In summary, the p.Ile5Met variant in SLC9A6 is classified as likely benign based on the ACMG/AMP criteria (BS1, BP4). LINK:https://erepo.genome.network/evrepo/ui/classification/CA10524605/MONDO:0010278/016

Frequency

Genomes: 𝑓 0.000072 ( 0 hom., 1 hem., cov: 22)
Exomes 𝑓: 0.000041 ( 0 hom. 21 hem. )

Consequence

SLC9A6
NM_001379110.1 missense

Scores

1
1
15

Clinical Significance

Likely benign reviewed by expert panel U:1B:4

Conservation

PhyloP100: -0.100
Variant links:
Genes affected
SLC9A6 (HGNC:11079): (solute carrier family 9 member A6) This gene encodes a sodium-hydrogen exchanger that is amember of the solute carrier family 9. The encoded protein localizes to early and recycling endosomes and may be involved in regulating endosomal pH and volume. Defects in this gene are associated with X-linked syndromic cognitive disability, Christianson type. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Apr 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -5 ACMG points.

BP4
For more information check the summary or visit ClinGen Evidence Repository.
BS1
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SLC9A6NM_001379110.1 linkuse as main transcriptc.15C>G p.Ile5Met missense_variant 2/18 ENST00000630721.3 NP_001366039.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SLC9A6ENST00000630721.3 linkuse as main transcriptc.15C>G p.Ile5Met missense_variant 2/184 NM_001379110.1 ENSP00000487486.2 A0A0D9SGH0
SLC9A6ENST00000370695.8 linkuse as main transcriptc.171C>G p.Ile57Met missense_variant 1/161 ENSP00000359729.4 Q92581-2
SLC9A6ENST00000370698.7 linkuse as main transcriptc.171C>G p.Ile57Met missense_variant 1/161 ENSP00000359732.3 Q92581-1
SLC9A6ENST00000370701.6 linkuse as main transcriptc.15C>G p.Ile5Met missense_variant 2/171 ENSP00000359735.1 Q92581-3

Frequencies

GnomAD3 genomes
AF:
0.0000715
AC:
8
AN:
111855
Hom.:
0
Cov.:
22
AF XY:
0.0000294
AC XY:
1
AN XY:
34029
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000151
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000382
AC:
7
AN:
183243
Hom.:
0
AF XY:
0.0000591
AC XY:
4
AN XY:
67737
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.000134
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000733
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000410
AC:
45
AN:
1098201
Hom.:
0
Cov.:
31
AF XY:
0.0000578
AC XY:
21
AN XY:
363567
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000511
Gnomad4 OTH exome
AF:
0.0000434
GnomAD4 genome
AF:
0.0000715
AC:
8
AN:
111855
Hom.:
0
Cov.:
22
AF XY:
0.0000294
AC XY:
1
AN XY:
34029
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000151
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000868
Hom.:
1
Bravo
AF:
0.0000680
ExAC
AF:
0.0000412
AC:
5
EpiCase
AF:
0.000273
EpiControl
AF:
0.00

ClinVar

Significance: Likely benign
Submissions summary: Uncertain:1Benign:4
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

Christianson syndrome Benign:3
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 24, 2024- -
Likely benign, reviewed by expert panelcurationClinGen Rett and Angelman-like Disorders Variant Curation Expert PanelMar 26, 2021The allele frequency of the p.Ile5Met variant in SLC9A6 is 0.013% in Ashkenazi Jewish sub population in gnomAD, which is high enough to be classified as likely benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BS1). Computational analysis prediction tools suggest that the p.Ile5Met variant does not have a deleterious impact; however this information does not predict clinical significance on its own (BP4). In summary, the p.Ile5Met variant in SLC9A6 is classified as likely benign based on the ACMG/AMP criteria (BS1, BP4). -
Likely benign, criteria provided, single submitterclinical testingCentre for Mendelian Genomics, University Medical Centre LjubljanaAug 29, 2019This variant was classified as: Likely benign. The following ACMG criteria were applied in classifying this variant: BS2,BP4. This variant was detected in hemizygous state. -
not provided Uncertain:1Benign:1
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJul 01, 2024SLC9A6: BS2 -
Uncertain significance, criteria provided, single submitterclinical testingGeneDxJan 27, 2017A variant of uncertain significance has been identified in the SLC9A6 gene. The I57M variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The I57M variant is observed in 3/47,771 alleles from individuals of European background, including multiple unrelated hemizygous individuals (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The I57M variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position where amino acids with similar properties to Isoleucine are tolerated across species. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.099
BayesDel_addAF
Benign
-0.36
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
16
DANN
Benign
0.97
DEOGEN2
Benign
0.15
.;.;.;.;.;.;.;T;T;.
FATHMM_MKL
Benign
0.54
D
LIST_S2
Benign
0.83
.;.;T;.;.;T;T;T;T;T
M_CAP
Uncertain
0.26
D
MetaRNN
Benign
0.11
T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.91
T
MutationAssessor
Benign
1.9
.;.;.;.;.;.;L;L;.;.
PrimateAI
Pathogenic
0.88
D
PROVEAN
Benign
-0.55
.;.;.;.;.;N;N;N;.;.
REVEL
Benign
0.070
Sift
Benign
0.17
.;.;.;.;.;T;T;T;.;.
Sift4G
Benign
0.29
.;.;.;.;.;T;T;T;T;.
Polyphen
0.92, 0.41
.;.;.;.;.;.;P;B;.;.
Vest4
0.34, 0.31, 0.28
MutPred
0.27
.;.;.;.;.;.;Loss of loop (P = 0.0986);Loss of loop (P = 0.0986);.;.;
MVP
0.29
MPC
1.1
ClinPred
0.038
T
GERP RS
0.32
Varity_R
0.15
gMVP
0.91

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs782296172; hg19: chrX-135067832; API